A definitive diagnosis of LNB requires evidence of possible exposure, signs and symptoms of nervous system disease, and supportive laboratory data. Because LNB frequently has clinical overlap with other medical illnesses, there are many obstacles and pitfalls to securing the diagnosis with laboratory confirmation. B burgdorferi can be identified by direct microscopy in tissue biopsies, electron microscopy, and by culture, but these methodologies are not readily available. [25] Polymerase chain reaction (PCR) for clinical samples has had a low sensitivity for blood and CSF in Lyme disease but has been useful on synovial fluid specimens in patients with Lyme arthritis. [8, 25]